Facebook Twitter RSS Feed
 - Stent

A biodegradable drug-eluting stent (DES) proved to be noninferior to durable-polymer DES and both showed benefits over bare-metal stents (BMS) in the BASKET-PROVE II clinical trial. The results published online Nov. 19 in Circulation also raise questions about triggers for late complications.

 - coronary artery calcium

Low-dose CT has become a mainstay for PET attenuation correction, but why not take it a step further by quantifying coronary artery calcium without adding any extra dose, according to an Ottawa Heart Institute study published ahead of print Nov. 20 in the Journal of Nuclear Cardiology.

 - question mark

The official position for catheter ablation as a treatment for atrial fibrillation in a draft technology assessment report for the Agency for Healthcare Research and Quality (AHRQ) is “can’t tell yet.” The draft report is open for review through Dec. 8.

 

 - cholesterol

Statin use could increase by at least a third under 2013 joint guidelines on cholesterol, according to a study published Nov. 19 in the Journal of the American College of Cardiology.

 - ecg, heart, electrophysiology

According to a study published Nov. 19 in JAMA, patients whose STEMI occurred in hospital had poorer outcomes than those whose STEMI occurred beyond the hospital doors.